Lyme vaccine test completion is pushed back by a year as Pfizer, Valneva say they'll adjust trial
Valneva and Pfizer have adjusted the end date for the Phase III study of their investigational Lyme disease vaccine, pushing it back by a year …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
